Guardian Pharmacy Services IncGRDN
Price$40.84Intrinsic value$39.124% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.5B+19.1% YoYTTM through 30 Jun 2026
Net Income $65.9MTTM through 30 Jun 2026
Free Cash Flow $94.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin21.6%
EBITDA Margin7.4%
Operating Margin5.0%
Net Margin4.5%

Returns

22.5%ROE
11.9%ROA
33.5%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.38x
Net Debt-$65.6Mnet cash position
Cash & Equivalents$89.8M

Quality Metrics

Altman Z-Score13.66
Piotroski F-Score9 / 9
FCF Margin6.4%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'24'25
FY2025: $1.4B

Dividend

No dividend

Capital Allocation

Capex Intensity0.3%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.